FDA awards grant for phase 1 clinical trial of experimental AML/MDS treatment

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)-;two related blood diseases that disproportionally strike older adults-;are notoriously difficult to treat and associated with high relapse rates.

Mushrooms Inc. (OTC:MSRM) Launches New Health Supplements, Progresses with German Partnership, and Boosts Engagement Initiatives | Psychedelic Invest

ESTERO, Fla., March 05, 2024 (GLOBE NEWSWIRE) — via IBN — Mushrooms Inc., (OTC: MSRM) a developing leader in biotechnology and sustainable healthcare innovation using mushrooms and mycelium,

March 5, 2024

Verano Q1 Revenue Falls

Verano Announces First Quarter 2024 Financial Results Generated $221 Million in Revenue, Exceeding Guidance Increased Gross Profit Margin by Nearly 300 Basis Points Year Over

May 8, 2024

Experts, Senators Wrestle Over Thorny Drug Shortage Challenge

Experts from industry and academia and lawmakers reached consensus around the dangers and the drivers of drug shortages but clashed over approaches to solving the

December 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.